Autopsy report · NCT00038389

Study of Vioxx and Radiation Therapy for Brainstem Glioma

“Unavailability of study drug.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months after it had already started.
• Ran for about 3 years 3 months before it stopped.
• 8 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

M.D. Anderson Cancer Center

Sponsor type

University, hospital or other

Conditions

Glioma; Brain Neoplasms

Interventions

Vioxx

Participants

8

Sites

1

Countries

United States

Trials that died the same way

• Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
  “study drug unavailable” (81% match in meaning)
• CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma
  “Study drug no longer available” (77% match in meaning)
• VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)
  “concerns related to study drug” (74% match in meaning)
• Exenatide For Reducing the Reinforcing Effects of Cocaine
  “The study was closed due to the inability to acquire the study drug.” (72% match in meaning)
• Topical Garlic Concentrate for Alopecia Areata in Children
  “Lack of efficacy of the study medication” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.